The size of the Genetic testing market in Latin America was worth USD 4.22 billion in 2022 and is forecasted to reach USD 5.95 billion by 2027 growing at a CAGR of 7.12% during the forecast period.
Genetic Testing is an attractive and fast-growing segment in the molecular diagnostics market as it helps in providing superior medical care. Any modifications in chromosomes, genes, or proteins that are associated with the inherited disease conditions can be identified through genetic testing.
The risk of diseases like identifying carriers of disease, diagnosing diseases, or determining the likely course of a disease can be predicted through genetic testing, which is basically an analysis of genes, chromosomes, or proteins. Diseases such as sickle cell anemia, hemophilia, and cystic fibrosis are easily diagnosed with the help of genetic testing, making life easier for patients.
With it, the potential to be able to diagnose and treat diseases and growing awareness among individuals about its benefits has led to the growth of the Latin American genetic testing market. In addition, advancements in the genetic testing space, the aging population and a subsequent rise in the number of chronic diseases, and rising incidences of cancer are the other driving forces for the genetic testing market.
An increase in the incidence of genetic diseases unravels new opportunities for genetic testing and its related applications. The transformation of genetic testing from a service-driven market to a product-driven market is anticipated to provide a push to the diagnostic companies for expanding their operations.
However, few factors hinder the growth of the Latin American genetic testing market, including the high cost associated with genetic testing being one. And also, many individuals are concerned about the authenticity of genetic reports owing to the lack of a credible standard procedure.
This research report on the Latin American Genetic Testing Market has been segmented and sub-segmented into the following categories.
By Application:
By Test:
By Country:
KEY MARKET PLAYERS:
Companies that are playing a leading role in the Latin American Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.
This report comes with:
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Design
2.3 Research Phases
2.3.1 Secondary Research
2.3.2 Primary Research
2.3.3 Econometric Modelling
2.3.4 Expert Validation
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Type
5.1.1 Carrier Testing
5.1.2 Diagnostic Testing
5.1.3 Prenatal Testing
5.1.4 Neonatal Testing
5.2 By Application
5.2.1 Cancer Testing
5.2.2 Prenatal Testing
5.2.3 Pharmacogenomics Testing
5.2.4 Presdisposition Testing
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Argentina
6.4 Mexico
6.5 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Roche Molecular Diagnostics Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Abbott Laboratories
8.3 AutoGenomics Inc.
8.4 Celera Group
8.5 ELITech Group
8.6 BioRad Laboratories
8.7 Quest Diagnostics Inc
8.8 Transgenomic Inc.
8.9 Applied Biosystems Inc.,
8.10 PerkinElmer Inc
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
